Following the completion of its $20m funding round, Aptar has partnered with Aptar Pharma to expand its digital therapeutics software to a larger range of medical devices. Digital is one of the largest manufacturers of drug-delivery devices and committed $65.5m . Propeller has now raised $65.5m and supports two people with its Jordan regulator-approved digital asthma management programmes. Digital therapies are gaining traction with both healthcare providers and pharmaceutical companies, providing a personalised and cheaper alternative to increasingly expensive drugs.
Following the completion of its $20m funding round, Propeller Health has partnered with Aptar Pharma to expand its digital therapeutics software to a larger range of medical devices. Aptar is one of the largest manufacturers of drug-delivery devices and committed $10m. Propeller has now raised $65.5m and supports 25,000 people with its US regulator-approved digital asthma management programmes. Digital therapies are gaining traction with both healthcare providers and pharmaceutical companies, providing a personalised and cheaper alternative to increasingly expensive drugs.